Francesk radi
Conclusion The higher 3-year survival rate in patients with retroperitoneal sarcomas when achieving Ro resection warrant further investigation with a larger sample size across different institutions.
There was a significant difference in the 3-year survival rate between patients having positive or negative surgical margins (p=0.027). In total, 16 (55.2%) patients were found to have a local recurrence, with no significant difference in patients' age, gender, tumour size, histology, negative surgical margin (Ro) resection, neoadjuvant chemotherapy, or radiation therapy. A 3-year follow-up was successful in 21 (72.4%) patients five (23.8%) patients died. Five (17.2%) patients received neoadjuvant radiation, four (13.8%) postoperative radiation, and three (10.3%) patients received both chemotherapy and radiation prior to surgery with the rest of the patients being treated with surgical excision alone. Negative margins were attained in 13 (44.8%) of all patients who underwent surgical resection. Tumours >5cm were presented in 27 (93.1%) patients.
Li-posarcomas (on histology) were identified in 19 (65.5%) patients, leiomyosarcoma six (20.7%), and other histologic subtypes in four (13.8%) patients. The mean age at diagnosis was 56.1 years 55.2% of patients were male (n=16). Results Data from 29 patients were analysed. Methods A retrospective analysis of adult patients treated at our hospital with a diagnosis of primary retroperitoneal sarcoma who underwent tumour resection. Aim To present the experience from collective data regarding patients with retroperitoneal sarcomas that have been operated in and followed up by the University General Hospital of Patras in Rion, Greece, between 20.